>
Powered by

Biohaven Closes Second Tranche Of Private Placement And Appoints Two New Directors To Board

 Portage Biotech Inc. ("Portage" or "the Company")(OTC: PTGEF, Canadian Securities Exchange: PBT.U), is pleased to announce that Biohaven Pharmaceutical Holding Company Ltd., wherein Portage has significant equity interest, has issued today a press release, which can be accessed athttp://www.prnewswire.com/news-releases/biohaven-closes-second-tranche-of-private-placement-and-appoints-two-new-directors-to-board-300418589.html

About Portage: 

Portage is engaged in the discovery and d

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox